A new survey aims to capture the publics feelings and preferences on priorities for the next generation of HIV treatments.

We’ve had had HIV treatments in a variety of forms for nearly three decades now,  AZT was approved for “the treatment of AIDS Patients” by the US FDA in 1987 – and in the past 27 years things have changed and improved dramatically.

We have single pill formulations, we have once a day combinations, we have ones you can take with, or without food, blue ones, pink ones and white ones. But as great as many of them are – they’re not perfect.

This survey, run by an international pharmaceutical company with the aid of a multi-discipline steering committee that consists of HIV clinicians, nurses, pharmacists, patient group representatives, and academics, is looking to gather opinions and priorities for the next treatment options from us – the people living with HIV.

If you are HIV-Positive, have 15 minutes and are interested in influencing the priorities for the next generation of HIV treatments please head to:

All data collected is anonymous.

beyondpositive was not involved in the creation of this survey and will not financially benefit from its completion or outcome.


Please enter your comment!
Please enter your name here